Our program encompasses physicians, clinicians, and a large, international team of laboratory-based and clinical investigators who are striving to find more effective therapies. It is part of the Division of Plasma Cell Neoplasias, focused on research and clinical care for plasma cell disorders. Physicians work closely with research scientists in a "bench-to-bedside" approach that identifies promising new treatments by rapidly translating laboratory discoveries into the clinical setting.
Kenneth C. Anderson, MD, Program Director
Paul G. Richardson, MD, Clinical Program Leader and Director of Clinical Research
Nikhil C. Munshi, MD, Director of Basic and Correlative Science
Jacob Laubach, MD, MPP, Clinical Director
Dharminder Chauhan, PhD
Ruben Carrasco, MD, PhD
Constantine Mitsiades, MD, PhD
Mehmet Samur, PhD
Yu-Tzu Tai, PhD
Jessica Croteau, NP
Tina Flaherty, NP
Catherine Flynn, NP
Katie Goodrich, NP
Jackie Haskell, NP
Natalie Kazierad, NP
Shannon Miller, NP
Eileen Regan, NP
Ann Marie Van Hof, NP
Emerald Chun, RN
Randi Doherty, RN
Kristen Donadio, RN
Meghan Gray, RN
Mackenna Katzeff, RN
Kara Keith, RN
Brittany Parker, RN (Float ONN)
Annemarie Rossi, RN
Sarah Schlosstein, RN (Float ONN)
Irina Dobrusin, RN
Kathryn Newcombe, RN
Tonia Valeri, RN
Sarah DeFranti, RN
Molly Hilliard, RN
Taylor Nicholson, RN
Emily Simpson, RN
